New layer of the human cornea discovered

Article

Researchers at the University of Nottingham, UK, have announced their discovery of a previously undetected layer in the cornea, the clear window at the front of the human eye.

Researchers at the University of Nottingham, UK, have announced their discovery of a previously undetected layer in the cornea, the clear window at the front of the human eye.

This research has been published in the journal Ophthalmology and could potentially lead the way to improved outcomes for patients requiring corneal transplants and grafts.

The layer will be called Dua’s layer after its discoverer Professor Harminder Dua and is located at the back of the cornea, between the corneal stroma and Descemet’s membrane.

“This is a major discovery that will mean that ophthalmology textbooks will literally need to be re-written. Having identified this new and distinct layer deep in the tissue of the cornea, we can now exploit its presence to make operations much safer and simpler for patients,” Professor Dua commented. “From a clinical perspective, there are many diseases that affect the back of the cornea, which clinicians across the world are already beginning to relate to the presence, absence or tear in this layer.”

The existence of this layer was proven through simulation of human corneal transplants and grafts on eyes donated for research. To do this the researchers injected tiny bubbles of air into the cornea to gently separate the various layers. Then each layer was subjected to electron microscopy to allow analysis to be performed at a vastly increased size.

It is thought that this discovery will help to further knowledge of a number of corneal diseases and in fact, the researchers of this work believe that a tear in Dua’s layer could be a reason for corneal hydrops, a bulging of the cornea through fluid build up in keratoconus patients.

Further information on this discovery can be found on the University of Nottingham's website here or the abstract may be found in Ophthalmology

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.